Earnings NewsHealthcareCNS Pharmaceuticals reports FY resultsMar. 03, 2022 8:50 AM ETCNS Pharmaceuticals, Inc. (CNSP)By: Deepa Sarvaiya, SA News Editor CNS Pharmaceuticals press release (NASDAQ:CNSP): FY Net Loss of $14M As of December 31, 2021, the Company had cash of approximately $5M and working capital of approximately $5.3M. Shares -1.24% PM. Recommended For You